Graves' disease and hyperthyroidism trials in United Kingdom

In United Kingdom 6 Also abroad 55

6 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Where
Gateshead
Age
18 years and over
People
230 worldwide
Run by
argenx
See details and how to joinNCT07570316 · EU 2025-524223-42-00
Phase 2Taking people
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Where
Cornwell, London, Merthyr Tydfil, Salford, Surrey
Age
18 years to 75 years
People
210 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00
Phase 2Taking people
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
Where
Milton Keynes, Newcastle upon Tyne
Age
18 years to 75 years
People
30 worldwide
Run by
Sanofi
See details and how to joinNCT06984627
Phase 2Enrolling by invitation
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
Where
Truro
Age
18 years and over
People
372 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT07286006
Phase 2Taking people
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Where
Birmingham, Bristol, Cambridge, Cardiff, Coventry, Edinburgh, Huddersfield, Hull, London, Manchester, Newcastle upon Tyne, Norwich, Nuneaton
Age
18 years to 75 years
People
240 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT06727604 · EU 2024-516020-33-00
No phaseTaking people
Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules
Where
Reading
Age
18 years and over
People
10
Run by
Royal Berkshire NHS Foundation Trust
See details and how to joinNCT07046546